DGAP-News: Bavarian Nordic–s IMVAMUNE(R) Smallpox Vaccine Highlighted as Success Story in WMD Center–s Bio-Response Report Card
Bavarian Nordic
13.10.2011 14:37
—————————————————————————
KVISTGARD, Denmark, 2011-10-13 14:37 CEST (GLOBE NEWSWIRE) —
Bavarian Nordic A/S (Copenhagan:BAVA) today applauded the release of the WMD
Center–s Bio-Response Report Card, which concluded that the response to the
threat of smallpox is one of the top success stories for biodefense during the
past decade. The bipartisan Report Card highlights the winning public-private
partnership bet
